Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddys Lab reports Profit after tax of Rs 4810.00 Mln, in the September 2020 quarter
Date: 28-10-2020
Revenue reduced marginally to stand at Rs. 33458.00 millions during the quarter ended September 2020. The figure stood at Rs. 34460.00 millions during the year-ago period.A big decline of -64.76% was reported for the quarter ended September 2020 to Rs. 4810.00 millions from Rs. 13651.00 millions of corresponding previous quarter.A decline of 8432.00 millions was observed in the OP in the quarter ended September 2020 from 12375.00 millions on QoQ basis.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202009 | 201909 | % Var | 202009 | 201909 | % Var | 202003 | 201903 | % Var | |
| Sales | 33458.00 | 34460.00 | -2.91 | 65902.00 | 59547.00 | 10.67 | 118504.00 | 106255.00 | 11.53 |
| Other Income | 266.00 | 767.00 | -65.32 | 6713.00 | 5481.00 | 22.48 | 7432.00 | 2384.00 | 211.74 |
| PBIDT | 8432.00 | 12375.00 | -31.86 | 24166.00 | 21396.00 | 12.95 | 36128.00 | 25381.00 | 42.34 |
| Interest | 93.00 | 122.00 | -23.77 | 233.00 | 243.00 | -4.12 | 478.00 | 568.00 | -15.85 |
| PBDT | 8339.00 | 12253.00 | -31.94 | 23933.00 | 21153.00 | 13.14 | 35650.00 | 24813.00 | 43.67 |
| Depreciation | 2142.00 | 2041.00 | 4.95 | 4119.00 | 4011.00 | 2.69 | 7892.00 | 7806.00 | 1.10 |
| PBT | 6197.00 | 10212.00 | -39.32 | 19814.00 | 17142.00 | 15.59 | 27758.00 | 17007.00 | 63.22 |
| TAX | 1387.00 | -3439.00 | -140.33 | 5502.00 | -1990.00 | -376.48 | -1619.00 | 4234.00 | -138.24 |
| Deferred Tax | 273.00 | -4968.00 | -105.50 | 1997.00 | -5047.00 | -139.57 | -6458.00 | 1416.00 | -556.07 |
| PAT | 4810.00 | 13651.00 | -64.76 | 14312.00 | 19132.00 | -25.19 | 29377.00 | 12773.00 | 129.99 |
| Equity | 831.00 | 831.00 | 0.00 | 831.00 | 831.00 | 0.00 | 831.00 | 830.00 | 0.12 |
| PBIDTM(%) | 25.20 | 35.91 | -29.82 | 36.67 | 35.93 | 2.05 | 30.49 | 23.89 | 27.63 |